[{"PropertyPlantAndEquipmentNet_0_Q2_USD":8979000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":8705197.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":748000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3058000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":3482000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":1364000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":124802000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":220403000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-1701000.0,"AssetsCurrent_0_Q2_USD":362562000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":703000.0,"OtherAssets_0_Q2_USD":9706000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q2_USD":724000.0,"CostOfGoodsAndServicesSoldAmortization_2_Q2_USD":965000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":262838.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-24481000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":366753000.0,"InventoryFinishedGoods_0_Q2_USD":668000.0,"FinanceLeaseInterestExpense_2_Q2_USD":5000.0,"InterestPaidNet_2_Q2_USD":0.0,"FinanceLeaseInterestExpense_1_Q2_USD":5000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":689000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":34380000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":717000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1260000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":283333000.0,"InterestExpenseOther_1_Q2_USD":172000.0,"InterestExpenseOther_2_Q2_USD":227000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":27.96,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":37.46,"OperatingLeaseRightOfUseAsset_0_Q2_USD":6419000.0,"ShareBasedCompensation_1_Q2_USD":11762000.0,"ShareBasedCompensation_2_Q2_USD":28641000.0,"Assets_0_Q2_USD":424255000.0,"CommonStockSharesIssued_0_Q2_shares":59525565.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":410000.0,"IncomeTaxesPaidNet_2_Q2_USD":0.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":159000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":11748000.0,"RestrictedCashCurrent_0_Q2_USD":1801000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":118123000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ProceedsFromIssuanceOfMandatoryRedeemableCapitalSecurities_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":658000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":1352000.0,"AccountsReceivableNetCurrent_0_Q2_USD":44796000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-119000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-216000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":41543000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":37000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":2895000.0,"InventoryRawMaterials_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4974000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":27.96,"ResearchAndDevelopmentExpense_1_Q2_USD":42425000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":98495000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-17000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":144000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":13713000.0,"CommonStockValue_0_Q2_USD":1199005000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":5131000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":297151000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":500000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":2895000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":58742329.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":57577384.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":19.46,"OperatingLeaseLiability_0_Q2_USD":3714000.0,"EquityMethodInvestments_0_Q2_USD":2473000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":8120648.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":62000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":10849000.0,"FinanceLeaseLiability_0_Q2_USD":2061000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3234000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":261061000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":934000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":752000.0,"IncreaseDecreaseInInventories_2_Q2_USD":6931000.0,"OtherAssetsCurrent_0_Q2_USD":7253000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":2220000.0,"CommonStockNoParValue_0_Q2_USD":0.0,"Liabilities_0_Q2_USD":459721000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1_Q2_shares":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":9698000.0,"OperatingIncomeLoss_1_Q2_USD":-160587000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":32096000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":14355000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":47735000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":263862000.0,"NonoperatingIncomeExpense_1_Q2_USD":-19689000.0,"NonoperatingIncomeExpense_2_Q2_USD":-40988000.0,"AccountsPayableCurrent_0_Q2_USD":17044000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":366753000.0,"LiabilitiesCurrent_0_Q2_USD":166417000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":675000.0,"SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_0_Q2_USD":127771000.0,"InventoryWorkInProcess_0_Q2_USD":8302000.0,"ProceedsFromWarrantExercises_2_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-326535000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11762000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0555,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":2895000.0,"InterestExpenseDebt_2_Q2_USD":12554000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-1485000.0,"InterestExpenseDebt_1_Q2_USD":6993000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":40535000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":240550000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":40535000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":1518142.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":-35466000.0,"AdvertisingExpense_1_Q2_USD":32007000.0,"AdvertisingExpense_2_Q2_USD":39515000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":21500000.0,"AdditionalPaidInCapital_0_Q2_USD":91773000.0,"ShortTermLeaseCost_1_Q2_USD":21000.0,"ShortTermLeaseCost_2_Q2_USD":64000.0,"SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent_0_Q2_USD":31250000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0805,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":32000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":32000.0,"GrossProfit_1_Q2_USD":6640000.0,"GrossProfit_2_Q2_USD":7367000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":310000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-2865000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":2895000.0,"RestrictedCashNoncurrent_0_Q2_USD":1000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":1449000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":480000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":47063.0,"GainLossOnSaleOfDerivatives_1_Q2_USD":650000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":2060000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":32195000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":424255000.0,"OperatingLeaseCost_1_Q2_USD":144000.0,"OperatingLeaseCost_2_Q2_USD":144000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.81,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":51.79,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2_Q2_USD":42821000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":0.0,"InventoryNet_0_Q2_USD":8970000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-180276000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-352519000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":2093000.0,"OperatingExpenses_2_Q2_USD":318898000.0,"OperatingExpenses_1_Q2_USD":167227000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3674000.0,"CommonStockSharesOutstanding_0_Q2_shares":59525565.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":44796000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-53865000.0,"PaymentsForTenantImprovements_2_Q2_USD":1600000.0,"LeaseCost_1_Q2_USD":229000.0,"LeaseCost_2_Q2_USD":277000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1326244000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4482647.0,"OperatingIncomeLoss_2_Q2_USD":-311531000.0,"VariableLeaseCost_1_Q2_USD":27000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":8120648.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1381000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":697000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4728000.0,"ProfitLoss_2_Q2_USD":-353871000.0,"ProfitLoss_1_Q2_USD":-180934000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-3.08,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-6.15,"VariableLeaseCost_2_Q2_USD":32000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2_Q2_shares":0.0,"Ticker":"BHVN","CIK":"1689813","name":"BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.","OfficialName":"Biohaven Pharmaceutical Holding Company Ltd. Common Shares","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7425158774.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200810"}]